Breaking News

DHL Group Acquires CRYOPDP from Cryoport

Enhances DHL’s capabilities in specialized pharma logistics and expands the breadth of its offering in the life science and healthcare sector.

Author Image

By: Charlie Sternberg

Associate Editor

DHL Group has acquired 100% of CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. In this context, DHL and Cryoport Inc. also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector. The deal and the outlined partnership are subject to regulatory approvals. Acquisition DHL Group already has an established Life Sciences and Healthcare business. Building on this fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters